| Drug-Target Information | ||||||||
|---|---|---|---|---|---|---|---|---|
| Drug Name | Target Name | Drug Type | Target Type | Source | Drug MeSHID | Interaction Score | Drug Status | Target Action |
| ethanol | voltage-dependent l-type calcium channel subunit alpha-1c | small molecule | NA | drugbank , DGIDB | Malignant Neoplasms[MeSHID:D009369] Disease[MeSHID:D004194] Ganglia[MeSHID:D005724] Trigeminal Neuralgia[MeSHID:D014277] Nerve Tissue[MeSHID:D009417] Chronic pain[MeSHID:D059350] Cystitis[MeSHID:D003556] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
0.07 | approved | unknown |
| ethanol | voltage-dependent l-type calcium channel subunit alpha-1d | small molecule | NA | drugbank | Malignant Neoplasms[MeSHID:D009369] Disease[MeSHID:D004194] Ganglia[MeSHID:D005724] Trigeminal Neuralgia[MeSHID:D014277] Nerve Tissue[MeSHID:D009417] Chronic pain[MeSHID:D059350] Cystitis[MeSHID:D003556] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
NA | approved | unknown |
| ethanol | voltage-dependent l-type calcium channel subunit alpha-1s | small molecule | NA | drugbank | Malignant Neoplasms[MeSHID:D009369] Disease[MeSHID:D004194] Ganglia[MeSHID:D005724] Trigeminal Neuralgia[MeSHID:D014277] Nerve Tissue[MeSHID:D009417] Chronic pain[MeSHID:D059350] Cystitis[MeSHID:D003556] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
NA | approved | unknown |
| ethanol | voltage-dependent l-type calcium channel subunit beta-1 | small molecule | NA | drugbank | Malignant Neoplasms[MeSHID:D009369] Disease[MeSHID:D004194] Ganglia[MeSHID:D005724] Trigeminal Neuralgia[MeSHID:D014277] Nerve Tissue[MeSHID:D009417] Chronic pain[MeSHID:D059350] Cystitis[MeSHID:D003556] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
NA | approved | unknown |
| ethanol | voltage-dependent calcium channel gamma-1 subunit | small molecule | NA | drugbank | Malignant Neoplasms[MeSHID:D009369] Disease[MeSHID:D004194] Ganglia[MeSHID:D005724] Trigeminal Neuralgia[MeSHID:D014277] Nerve Tissue[MeSHID:D009417] Chronic pain[MeSHID:D059350] Cystitis[MeSHID:D003556] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
NA | approved | unknown |
| ethanol | voltage-dependent calcium channel gamma-2 subunit | small molecule | NA | drugbank | Malignant Neoplasms[MeSHID:D009369] Disease[MeSHID:D004194] Ganglia[MeSHID:D005724] Trigeminal Neuralgia[MeSHID:D014277] Nerve Tissue[MeSHID:D009417] Chronic pain[MeSHID:D059350] Cystitis[MeSHID:D003556] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
NA | approved | unknown |
| ethanol | neuronal acetylcholine receptor subunit alpha-10 | small molecule | NA | drugbank | Malignant Neoplasms[MeSHID:D009369] Disease[MeSHID:D004194] Ganglia[MeSHID:D005724] Trigeminal Neuralgia[MeSHID:D014277] Nerve Tissue[MeSHID:D009417] Chronic pain[MeSHID:D059350] Cystitis[MeSHID:D003556] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
NA | approved | unknown |
| ethanol | neuronal acetylcholine receptor subunit alpha-2 | small molecule | NA | drugbank | Malignant Neoplasms[MeSHID:D009369] Disease[MeSHID:D004194] Ganglia[MeSHID:D005724] Trigeminal Neuralgia[MeSHID:D014277] Nerve Tissue[MeSHID:D009417] Chronic pain[MeSHID:D059350] Cystitis[MeSHID:D003556] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
NA | approved | unknown |
| ethanol | neuronal acetylcholine receptor subunit alpha-3 | small molecule | NA | drugbank , DGIDB | Malignant Neoplasms[MeSHID:D009369] Disease[MeSHID:D004194] Ganglia[MeSHID:D005724] Trigeminal Neuralgia[MeSHID:D014277] Nerve Tissue[MeSHID:D009417] Chronic pain[MeSHID:D059350] Cystitis[MeSHID:D003556] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
0.11 | approved | unknown |
| ethanol | neuronal acetylcholine receptor subunit alpha-4 | small molecule | NA | drugbank , DGIDB | Malignant Neoplasms[MeSHID:D009369] Disease[MeSHID:D004194] Ganglia[MeSHID:D005724] Trigeminal Neuralgia[MeSHID:D014277] Nerve Tissue[MeSHID:D009417] Chronic pain[MeSHID:D059350] Cystitis[MeSHID:D003556] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
0.07 | approved | unknown |
| ethanol | neuronal acetylcholine receptor subunit alpha-5 | small molecule | NA | drugbank , DGIDB | Malignant Neoplasms[MeSHID:D009369] Disease[MeSHID:D004194] Ganglia[MeSHID:D005724] Trigeminal Neuralgia[MeSHID:D014277] Nerve Tissue[MeSHID:D009417] Chronic pain[MeSHID:D059350] Cystitis[MeSHID:D003556] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
0.56 | approved | unknown |
| ethanol | neuronal acetylcholine receptor subunit alpha-6 | small molecule | NA | drugbank | Malignant Neoplasms[MeSHID:D009369] Disease[MeSHID:D004194] Ganglia[MeSHID:D005724] Trigeminal Neuralgia[MeSHID:D014277] Nerve Tissue[MeSHID:D009417] Chronic pain[MeSHID:D059350] Cystitis[MeSHID:D003556] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
NA | approved | unknown |
| ethanol | neuronal acetylcholine receptor subunit alpha-7 | small molecule | NA | drugbank | Malignant Neoplasms[MeSHID:D009369] Disease[MeSHID:D004194] Ganglia[MeSHID:D005724] Trigeminal Neuralgia[MeSHID:D014277] Nerve Tissue[MeSHID:D009417] Chronic pain[MeSHID:D059350] Cystitis[MeSHID:D003556] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
NA | approved | unknown |
| ethanol | neuronal acetylcholine receptor subunit alpha-9 | small molecule | NA | drugbank | Malignant Neoplasms[MeSHID:D009369] Disease[MeSHID:D004194] Ganglia[MeSHID:D005724] Trigeminal Neuralgia[MeSHID:D014277] Nerve Tissue[MeSHID:D009417] Chronic pain[MeSHID:D059350] Cystitis[MeSHID:D003556] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
NA | approved | unknown |
| ethanol | neuronal acetylcholine receptor subunit beta-2 | small molecule | NA | drugbank | Malignant Neoplasms[MeSHID:D009369] Disease[MeSHID:D004194] Ganglia[MeSHID:D005724] Trigeminal Neuralgia[MeSHID:D014277] Nerve Tissue[MeSHID:D009417] Chronic pain[MeSHID:D059350] Cystitis[MeSHID:D003556] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
NA | approved | unknown |
| ethanol | neuronal acetylcholine receptor subunit beta-3 | small molecule | NA | drugbank | Malignant Neoplasms[MeSHID:D009369] Disease[MeSHID:D004194] Ganglia[MeSHID:D005724] Trigeminal Neuralgia[MeSHID:D014277] Nerve Tissue[MeSHID:D009417] Chronic pain[MeSHID:D059350] Cystitis[MeSHID:D003556] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
NA | approved | unknown |
| ethanol | neuronal acetylcholine receptor subunit beta-4 | small molecule | NA | drugbank | Malignant Neoplasms[MeSHID:D009369] Disease[MeSHID:D004194] Ganglia[MeSHID:D005724] Trigeminal Neuralgia[MeSHID:D014277] Nerve Tissue[MeSHID:D009417] Chronic pain[MeSHID:D059350] Cystitis[MeSHID:D003556] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
NA | approved | unknown |
| ethanol | gaba(a) receptor alpha-1 | NA | Successful target | TTD , DGIDB | Malignant Neoplasms[MeSHID:D009369] Disease[MeSHID:D004194] Ganglia[MeSHID:D005724] Trigeminal Neuralgia[MeSHID:D014277] Nerve Tissue[MeSHID:D009417] Chronic pain[MeSHID:D059350] Cystitis[MeSHID:D003556] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
0.05 | approved | unknown |
| ethanol | gamma-aminobutyric acid receptor subunit alpha-1 | small molecule | NA | drugbank , DGIDB | Malignant Neoplasms[MeSHID:D009369] Disease[MeSHID:D004194] Ganglia[MeSHID:D005724] Trigeminal Neuralgia[MeSHID:D014277] Nerve Tissue[MeSHID:D009417] Chronic pain[MeSHID:D059350] Cystitis[MeSHID:D003556] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
0.05 | approved | agonist |
| ethanol | gamma-aminobutyric acid receptor subunit alpha-2 | small molecule | NA | drugbank | Malignant Neoplasms[MeSHID:D009369] Disease[MeSHID:D004194] Ganglia[MeSHID:D005724] Trigeminal Neuralgia[MeSHID:D014277] Nerve Tissue[MeSHID:D009417] Chronic pain[MeSHID:D059350] Cystitis[MeSHID:D003556] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
NA | approved | unknown |
| ethanol | gamma-aminobutyric acid receptor subunit alpha-3 | small molecule | NA | drugbank | Malignant Neoplasms[MeSHID:D009369] Disease[MeSHID:D004194] Ganglia[MeSHID:D005724] Trigeminal Neuralgia[MeSHID:D014277] Nerve Tissue[MeSHID:D009417] Chronic pain[MeSHID:D059350] Cystitis[MeSHID:D003556] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
NA | approved | unknown |
| ethanol | gamma-aminobutyric acid receptor subunit alpha-4 | small molecule | NA | drugbank | Malignant Neoplasms[MeSHID:D009369] Disease[MeSHID:D004194] Ganglia[MeSHID:D005724] Trigeminal Neuralgia[MeSHID:D014277] Nerve Tissue[MeSHID:D009417] Chronic pain[MeSHID:D059350] Cystitis[MeSHID:D003556] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
NA | approved | unknown |
| ethanol | gamma-aminobutyric acid receptor subunit alpha-5 | small molecule | NA | drugbank | Malignant Neoplasms[MeSHID:D009369] Disease[MeSHID:D004194] Ganglia[MeSHID:D005724] Trigeminal Neuralgia[MeSHID:D014277] Nerve Tissue[MeSHID:D009417] Chronic pain[MeSHID:D059350] Cystitis[MeSHID:D003556] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
NA | approved | unknown |
| ethanol | gamma-aminobutyric acid receptor subunit alpha-6 | small molecule | NA | drugbank | Malignant Neoplasms[MeSHID:D009369] Disease[MeSHID:D004194] Ganglia[MeSHID:D005724] Trigeminal Neuralgia[MeSHID:D014277] Nerve Tissue[MeSHID:D009417] Chronic pain[MeSHID:D059350] Cystitis[MeSHID:D003556] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
NA | approved | unknown |
| ethanol | gamma-aminobutyric acid receptor subunit beta-1 | small molecule | NA | drugbank | Malignant Neoplasms[MeSHID:D009369] Disease[MeSHID:D004194] Ganglia[MeSHID:D005724] Trigeminal Neuralgia[MeSHID:D014277] Nerve Tissue[MeSHID:D009417] Chronic pain[MeSHID:D059350] Cystitis[MeSHID:D003556] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
NA | approved | unknown |
| ethanol | gamma-aminobutyric acid receptor subunit beta-2 | small molecule | NA | drugbank | Malignant Neoplasms[MeSHID:D009369] Disease[MeSHID:D004194] Ganglia[MeSHID:D005724] Trigeminal Neuralgia[MeSHID:D014277] Nerve Tissue[MeSHID:D009417] Chronic pain[MeSHID:D059350] Cystitis[MeSHID:D003556] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
NA | approved | unknown |
| ethanol | gamma-aminobutyric acid receptor subunit beta-3 | small molecule | NA | drugbank | Malignant Neoplasms[MeSHID:D009369] Disease[MeSHID:D004194] Ganglia[MeSHID:D005724] Trigeminal Neuralgia[MeSHID:D014277] Nerve Tissue[MeSHID:D009417] Chronic pain[MeSHID:D059350] Cystitis[MeSHID:D003556] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
NA | approved | unknown |
| ethanol | gamma-aminobutyric acid receptor subunit delta | small molecule | NA | drugbank | Malignant Neoplasms[MeSHID:D009369] Disease[MeSHID:D004194] Ganglia[MeSHID:D005724] Trigeminal Neuralgia[MeSHID:D014277] Nerve Tissue[MeSHID:D009417] Chronic pain[MeSHID:D059350] Cystitis[MeSHID:D003556] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
NA | approved | unknown |
| ethanol | gamma-aminobutyric acid receptor subunit epsilon | small molecule | NA | drugbank | Malignant Neoplasms[MeSHID:D009369] Disease[MeSHID:D004194] Ganglia[MeSHID:D005724] Trigeminal Neuralgia[MeSHID:D014277] Nerve Tissue[MeSHID:D009417] Chronic pain[MeSHID:D059350] Cystitis[MeSHID:D003556] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
NA | approved | unknown |
| ethanol | gamma-aminobutyric acid receptor subunit gamma-1 | small molecule | NA | drugbank | Malignant Neoplasms[MeSHID:D009369] Disease[MeSHID:D004194] Ganglia[MeSHID:D005724] Trigeminal Neuralgia[MeSHID:D014277] Nerve Tissue[MeSHID:D009417] Chronic pain[MeSHID:D059350] Cystitis[MeSHID:D003556] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
NA | approved | unknown |
| ethanol | gamma-aminobutyric acid receptor subunit gamma-3 | small molecule | NA | drugbank | Malignant Neoplasms[MeSHID:D009369] Disease[MeSHID:D004194] Ganglia[MeSHID:D005724] Trigeminal Neuralgia[MeSHID:D014277] Nerve Tissue[MeSHID:D009417] Chronic pain[MeSHID:D059350] Cystitis[MeSHID:D003556] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
NA | approved | unknown |
| ethanol | gamma-aminobutyric acid receptor subunit pi | small molecule | NA | drugbank | Malignant Neoplasms[MeSHID:D009369] Disease[MeSHID:D004194] Ganglia[MeSHID:D005724] Trigeminal Neuralgia[MeSHID:D014277] Nerve Tissue[MeSHID:D009417] Chronic pain[MeSHID:D059350] Cystitis[MeSHID:D003556] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
NA | approved | unknown |
| ethanol | gamma-aminobutyric acid receptor subunit theta | small molecule | NA | drugbank | Malignant Neoplasms[MeSHID:D009369] Disease[MeSHID:D004194] Ganglia[MeSHID:D005724] Trigeminal Neuralgia[MeSHID:D014277] Nerve Tissue[MeSHID:D009417] Chronic pain[MeSHID:D059350] Cystitis[MeSHID:D003556] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
NA | approved | unknown |
| ethanol | glycine receptor subunit alpha-1 | small molecule | NA | drugbank | Malignant Neoplasms[MeSHID:D009369] Disease[MeSHID:D004194] Ganglia[MeSHID:D005724] Trigeminal Neuralgia[MeSHID:D014277] Nerve Tissue[MeSHID:D009417] Chronic pain[MeSHID:D059350] Cystitis[MeSHID:D003556] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
NA | approved | agonist |
| ethanol | glycine receptor subunit alpha-2 | small molecule | NA | drugbank | Malignant Neoplasms[MeSHID:D009369] Disease[MeSHID:D004194] Ganglia[MeSHID:D005724] Trigeminal Neuralgia[MeSHID:D014277] Nerve Tissue[MeSHID:D009417] Chronic pain[MeSHID:D059350] Cystitis[MeSHID:D003556] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
NA | approved | agonist |
| ethanol | glutamate receptor 1 | small molecule | NA | drugbank | Malignant Neoplasms[MeSHID:D009369] Disease[MeSHID:D004194] Ganglia[MeSHID:D005724] Trigeminal Neuralgia[MeSHID:D014277] Nerve Tissue[MeSHID:D009417] Chronic pain[MeSHID:D059350] Cystitis[MeSHID:D003556] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
NA | approved | unknown |
| ethanol | glutamate receptor 2 | small molecule | NA | drugbank | Malignant Neoplasms[MeSHID:D009369] Disease[MeSHID:D004194] Ganglia[MeSHID:D005724] Trigeminal Neuralgia[MeSHID:D014277] Nerve Tissue[MeSHID:D009417] Chronic pain[MeSHID:D059350] Cystitis[MeSHID:D003556] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
NA | approved | unknown |
| ethanol | glutamate receptor 3 | small molecule | NA | drugbank | Malignant Neoplasms[MeSHID:D009369] Disease[MeSHID:D004194] Ganglia[MeSHID:D005724] Trigeminal Neuralgia[MeSHID:D014277] Nerve Tissue[MeSHID:D009417] Chronic pain[MeSHID:D059350] Cystitis[MeSHID:D003556] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
NA | approved | unknown |
| ethanol | glutamate receptor 4 | small molecule | NA | drugbank | Malignant Neoplasms[MeSHID:D009369] Disease[MeSHID:D004194] Ganglia[MeSHID:D005724] Trigeminal Neuralgia[MeSHID:D014277] Nerve Tissue[MeSHID:D009417] Chronic pain[MeSHID:D059350] Cystitis[MeSHID:D003556] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
NA | approved | unknown |
| ethanol | glutamate receptor ionotropic, nmda 3a | small molecule | NA | drugbank | Malignant Neoplasms[MeSHID:D009369] Disease[MeSHID:D004194] Ganglia[MeSHID:D005724] Trigeminal Neuralgia[MeSHID:D014277] Nerve Tissue[MeSHID:D009417] Chronic pain[MeSHID:D059350] Cystitis[MeSHID:D003556] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
NA | approved | antagonist |
| ethanol | 5-hydroxytryptamine receptor 3a | small molecule | NA | drugbank | Malignant Neoplasms[MeSHID:D009369] Disease[MeSHID:D004194] Ganglia[MeSHID:D005724] Trigeminal Neuralgia[MeSHID:D014277] Nerve Tissue[MeSHID:D009417] Chronic pain[MeSHID:D059350] Cystitis[MeSHID:D003556] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
NA | approved | unknown |
| ethanol | 5-hydroxytryptamine receptor 3b | small molecule | NA | drugbank | Malignant Neoplasms[MeSHID:D009369] Disease[MeSHID:D004194] Ganglia[MeSHID:D005724] Trigeminal Neuralgia[MeSHID:D014277] Nerve Tissue[MeSHID:D009417] Chronic pain[MeSHID:D059350] Cystitis[MeSHID:D003556] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
NA | approved | unknown |
| ethanol | 5-hydroxytryptamine receptor 3c | small molecule | NA | drugbank | Malignant Neoplasms[MeSHID:D009369] Disease[MeSHID:D004194] Ganglia[MeSHID:D005724] Trigeminal Neuralgia[MeSHID:D014277] Nerve Tissue[MeSHID:D009417] Chronic pain[MeSHID:D059350] Cystitis[MeSHID:D003556] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
NA | approved | unknown |
| ethanol | 5-hydroxytryptamine receptor 3d | small molecule | NA | drugbank | Malignant Neoplasms[MeSHID:D009369] Disease[MeSHID:D004194] Ganglia[MeSHID:D005724] Trigeminal Neuralgia[MeSHID:D014277] Nerve Tissue[MeSHID:D009417] Chronic pain[MeSHID:D059350] Cystitis[MeSHID:D003556] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
NA | approved | unknown |
| ethanol | 5-hydroxytryptamine receptor 3e | small molecule | NA | drugbank | Malignant Neoplasms[MeSHID:D009369] Disease[MeSHID:D004194] Ganglia[MeSHID:D005724] Trigeminal Neuralgia[MeSHID:D014277] Nerve Tissue[MeSHID:D009417] Chronic pain[MeSHID:D059350] Cystitis[MeSHID:D003556] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
NA | approved | unknown |
| ethanol | g protein-activated inward rectifier potassium channel 1 | small molecule | NA | drugbank | Malignant Neoplasms[MeSHID:D009369] Disease[MeSHID:D004194] Ganglia[MeSHID:D005724] Trigeminal Neuralgia[MeSHID:D014277] Nerve Tissue[MeSHID:D009417] Chronic pain[MeSHID:D059350] Cystitis[MeSHID:D003556] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
NA | approved | unknown |
| ethanol | g protein-activated inward rectifier potassium channel 4 | small molecule | NA | drugbank | Malignant Neoplasms[MeSHID:D009369] Disease[MeSHID:D004194] Ganglia[MeSHID:D005724] Trigeminal Neuralgia[MeSHID:D014277] Nerve Tissue[MeSHID:D009417] Chronic pain[MeSHID:D059350] Cystitis[MeSHID:D003556] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
NA | approved | unknown |
| ethanol | g protein-activated inward rectifier potassium channel 2 | small molecule | NA | drugbank | Malignant Neoplasms[MeSHID:D009369] Disease[MeSHID:D004194] Ganglia[MeSHID:D005724] Trigeminal Neuralgia[MeSHID:D014277] Nerve Tissue[MeSHID:D009417] Chronic pain[MeSHID:D059350] Cystitis[MeSHID:D003556] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
NA | approved | unknown |
| ethanol | g protein-activated inward rectifier potassium channel 3 | small molecule | NA | drugbank | Malignant Neoplasms[MeSHID:D009369] Disease[MeSHID:D004194] Ganglia[MeSHID:D005724] Trigeminal Neuralgia[MeSHID:D014277] Nerve Tissue[MeSHID:D009417] Chronic pain[MeSHID:D059350] Cystitis[MeSHID:D003556] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
NA | approved | unknown |
| ethanol | neural cell adhesion molecule l1 | small molecule | NA | drugbank | Malignant Neoplasms[MeSHID:D009369] Disease[MeSHID:D004194] Ganglia[MeSHID:D005724] Trigeminal Neuralgia[MeSHID:D014277] Nerve Tissue[MeSHID:D009417] Chronic pain[MeSHID:D059350] Cystitis[MeSHID:D003556] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
NA | approved | unknown |
| ethanol | equilibrative nucleoside transporter 1 | small molecule | NA | drugbank , DGIDB | Malignant Neoplasms[MeSHID:D009369] Disease[MeSHID:D004194] Ganglia[MeSHID:D005724] Trigeminal Neuralgia[MeSHID:D014277] Nerve Tissue[MeSHID:D009417] Chronic pain[MeSHID:D059350] Cystitis[MeSHID:D003556] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
0.16 | approved | unknown |
| ethanol | equilibrative nucleoside transporter 2 | small molecule | NA | drugbank | Malignant Neoplasms[MeSHID:D009369] Disease[MeSHID:D004194] Ganglia[MeSHID:D005724] Trigeminal Neuralgia[MeSHID:D014277] Nerve Tissue[MeSHID:D009417] Chronic pain[MeSHID:D059350] Cystitis[MeSHID:D003556] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
NA | approved | unknown |
| ethanol | vascular cell adhesion protein 1 | small molecule | NA | drugbank | Malignant Neoplasms[MeSHID:D009369] Disease[MeSHID:D004194] Ganglia[MeSHID:D005724] Trigeminal Neuralgia[MeSHID:D014277] Nerve Tissue[MeSHID:D009417] Chronic pain[MeSHID:D059350] Cystitis[MeSHID:D003556] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
NA | approved | unknown |
| click here to return to the previous page | ||||||||